AMSilk
The company produces biogenic silk protein materials using DNA editing, protein engineering, and precision fermentation. These man-made proteins are processed into fibers, yarns, sprayable formulations, hydrogels, and powders. The products serve as biobased alternatives to fossil and animal-based materials for the textile, medical, and consumer goods industries.
Visit websiteNeuried, Germany
Biotech
Advanced Materials
Textiles
Healthcare
Consumer Goods
Funding summary
- Total raised
- €77.0M
- Funding rounds
- 2
Investors in AMSilk
Investors on record for AMSilk. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like AMSilk?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors